Cargando…

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping

Treatment-resistant depression (TRD) occurs in ~30% of patients with major depressive disorder (MDD) but the genetics of TRD was previously poorly investigated. Whole exome sequencing and genome-wide genotyping were available in 1209 MDD patients after quality control. Antidepressant response was co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabbri, Chiara, Kasper, Siegfried, Kautzky, Alexander, Zohar, Joseph, Souery, Daniel, Montgomery, Stuart, Albani, Diego, Forloni, Gianluigi, Ferentinos, Panagiotis, Rujescu, Dan, Mendlewicz, Julien, Uher, Rudolf, Lewis, Cathryn M., Serretti, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026437/ https://www.ncbi.nlm.nih.gov/pubmed/32066715 http://dx.doi.org/10.1038/s41398-020-0738-5

Ejemplares similares

Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation
por: Fanelli, Giuseppe, et al.
Publicado: (2022)

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives
por: Fabbri, Chiara, et al.
Publicado: (2018)

Age as a moderating factor of treatment resistance in depression
por: Kautzky, Alexander, et al.
Publicado: (2023)

The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
por: Bartova, Lucie, et al.
Publicado: (2021)

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
por: Dold, Markus, et al.
Publicado: (2018)

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
por: Fugger, Gernot, et al.
Publicado: (2022)

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers
por: Bartova, Lucie, et al.
Publicado: (2016)

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
por: Kautzky, A., et al.
Publicado: (2018)

PS87. An update on prediction of treatment outcome in treatment resistant depression
por: Kautzky, Alexander, et al.
Publicado: (2016)

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
por: Dold, M., et al.
Publicado: (2018)

Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
por: Fugger, Gernot, et al.
Publicado: (2020)

Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder
por: Bartova, L., et al.
Publicado: (2022)

Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample
por: Zaninotto, Leonardo, et al.
Publicado: (2015)

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study
por: Schosser, Alexandra, et al.
Publicado: (2017)

Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression
por: Bartova, Lucie, et al.
Publicado: (2021)

Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database
por: Kraus, Christoph, et al.
Publicado: (2023)

Exome sequencing in an Italian family with Alzheimer’s disease points to a role for seizure-related gene 6 (SEZ6) rare variant R615H
por: Paracchini, Lara, et al.
Publicado: (2018)

Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment
por: Fabbri, Chiara, et al.
Publicado: (2020)

Possible Modulatory Role of ARC Gene Variants in Mood Disorders
por: Crisafulli, Concetta, et al.
Publicado: (2021)

Case Report: Identification of Polygenic Mutations by Exome Sequencing
por: Liu, Yanfeng, et al.
Publicado: (2021)

3D brain tissue physiological model with co-cultured primary neurons and glial cells in hydrogels
por: Raimondi, Ilaria, et al.
Publicado: (2020)

Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders
por: Fanizza, Francesca, et al.
Publicado: (2022)

Interleukin-1 Beta in Peripheral Blood Mononuclear Cell Lysates as a Longitudinal Biomarker of Response to Antidepressants: A Pilot Study
por: Ferentinos, Panagiotis, et al.
Publicado: (2021)

Exome arrays capture polygenic rare variant contributions to schizophrenia
por: Richards, A. L., et al.
Publicado: (2016)

Frontotemporal Lobar Degeneration and MicroRNAs
por: Piscopo, Paola, et al.
Publicado: (2016)

Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts
por: Ward, Joey, et al.
Publicado: (2018)

Polygenic risk for circulating reproductive hormone levels and their influence on hippocampal volume and depression susceptibility
por: Smeeth, Demelza M., et al.
Publicado: (2019)

Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank
por: Fabbri, Chiara, et al.
Publicado: (2023)

Prospects for using risk scores in polygenic medicine
por: Lewis, Cathryn M., et al.
Publicado: (2017)

PRSice: Polygenic Risk Score software
por: Euesden, Jack, et al.
Publicado: (2015)

Development of an Induced Pluripotent Stem Cell-Based Liver-on-a-Chip Assessed with an Alzheimer’s Disease Drug
por: Fanizza, Francesca, et al.
Publicado: (2023)

Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression
por: Kautzky, Alexander, et al.
Publicado: (2019)

Correction: Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression
por: Kautzky, Alexander, et al.
Publicado: (2019)

Polygenic risk scores: from research tools to clinical instruments
por: Lewis, Cathryn M., et al.
Publicado: (2020)

Towards achieving remission in the treatment of depression
por: Mendlewicz, Julien
Publicado: (2008)

Genotype imputation and variability in polygenic risk score estimation
por: Chen, Shang-Fu, et al.
Publicado: (2020)

Alzheimer’s disease: from basic science to precision medicine approach
por: Forloni, Gianluigi
Publicado: (2020)

Alpha Synuclein: Neurodegeneration and Inflammation
por: Forloni, Gianluigi
Publicado: (2023)

Oligomers and Neurodegeneration: New Evidence
por: Forloni, Gianluigi
Publicado: (2023)

Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing
por: Fabbri, Chiara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kvu4l3v801pm0g3nc3f98h97a1